Agreement Between Labial Biopsy and the OMERACT Grey-scale Ultrasound Scoring System for Salivary Glands in a Single-center Cohort of Patients with Suspected Sjögren’s Syndrome

Abstract

Background/Purpose:
Ultrasound is a promising non-invasive tool in the evaluation of the salivary glands for parenchymal changes related to Sjögrens Syndrome (SS). The OMERACT Ultrasound Grey-scale (GS) Scoring System for SS has been shown to have good sensitivity and excellent specificity for fulfilling the SS classification criteria, when a GS ≥2 in at least 1 gland was considered indicative of SS (1), however others have suggested pathology in at least 2 glands is required (2). Systematic use of ultrasound might reduce the need for labial biopsies if US findings are in agreement with biopsies.
Original languageEnglish
Publication date2022
Publication statusPublished - 2022
EventACR 2022 - Philadelphia
Duration: 10 Nov 202214 Nov 2022

Conference

ConferenceACR 2022
CityPhiladelphia
Period10/11/202214/11/2022

Fingerprint

Dive into the research topics of 'Agreement Between Labial Biopsy and the OMERACT Grey-scale Ultrasound Scoring System for Salivary Glands in a Single-center Cohort of Patients with Suspected Sjögren’s Syndrome'. Together they form a unique fingerprint.

Cite this